290 related articles for article (PubMed ID: 23908595)
21. CKD712, a synthetic isoquinoline alkaloid, enhances the anti-cancer effects of paclitaxel in MDA-MB-231 cells through regulation of PTEN.
Kim YM; Tsoyi K; Jang HJ; Park EJ; Park SW; Kim HJ; Hwa JS; Chang KC
Life Sci; 2014 Sep; 112(1-2):49-58. PubMed ID: 25058922
[TBL] [Abstract][Full Text] [Related]
22. p53-dependent regulation of Mcl-1 contributes to synergistic cell death by ionizing radiation and the Bcl-2/Bcl-XL inhibitor ABT-737.
Tagscherer KE; Fassl A; Sinkovic T; Combs SE; Roth W
Apoptosis; 2012 Feb; 17(2):187-99. PubMed ID: 22002102
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
Mayo LD; Seo YR; Jackson MW; Smith ML; Rivera Guzman J; Korgaonkar CK; Donner DB
J Biol Chem; 2005 Jul; 280(28):25953-9. PubMed ID: 15843377
[TBL] [Abstract][Full Text] [Related]
24. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
[TBL] [Abstract][Full Text] [Related]
25. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
26. c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL.
Maclean KH; Keller UB; Rodriguez-Galindo C; Nilsson JA; Cleveland JL
Mol Cell Biol; 2003 Oct; 23(20):7256-70. PubMed ID: 14517295
[TBL] [Abstract][Full Text] [Related]
27. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
[TBL] [Abstract][Full Text] [Related]
28. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
Arif T; Krelin Y; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
[TBL] [Abstract][Full Text] [Related]
29. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
[TBL] [Abstract][Full Text] [Related]
30. A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.
Kim J; Roh M; Doubinskaia I; Algarroba GN; Eltoum IE; Abdulkadir SA
Oncogene; 2012 Jan; 31(3):322-32. PubMed ID: 21685943
[TBL] [Abstract][Full Text] [Related]
31. Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro.
Burmakin M; Shi Y; Hedström E; Kogner P; Selivanova G
Clin Cancer Res; 2013 Sep; 19(18):5092-103. PubMed ID: 23864164
[TBL] [Abstract][Full Text] [Related]
32. Radiation/paclitaxel treatment of p53-abnormal non-small cell lung cancer xenograft tumor and associated mechanism.
Li G; Zhao J; Peng X; Liang J; Deng X; Chen Y
Cancer Biother Radiopharm; 2012 May; 27(4):227-33. PubMed ID: 22489661
[TBL] [Abstract][Full Text] [Related]
33. RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis.
Cho H; Herzka T; Zheng W; Qi J; Wilkinson JE; Bradner JE; Robinson BD; Castillo-Martin M; Cordon-Cardo C; Trotman LC
Cancer Discov; 2014 Mar; 4(3):318-33. PubMed ID: 24444712
[TBL] [Abstract][Full Text] [Related]
34. Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status.
Djuzenova CS; Fiedler V; Memmel S; Katzer A; Hartmann S; Krohne G; Zimmermann H; Scholz CJ; Polat B; Flentje M; Sukhorukov VL
Exp Cell Res; 2015 Jan; 330(2):346-357. PubMed ID: 25149900
[TBL] [Abstract][Full Text] [Related]
35. PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma.
Liu YY; Yao SN; Zhao Y; Yao ZH; Ma J; Xia QX; Fu K; Yang SJ
Leuk Lymphoma; 2010 Sep; 51(9):1692-8. PubMed ID: 20807096
[TBL] [Abstract][Full Text] [Related]
36. PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.
Costa PM; Cardoso AL; Pereira de Almeida LF; Bruce JN; Canoll P; Pedroso de Lima MC
Hum Mol Genet; 2012 Dec; 21(23):5118-30. PubMed ID: 22922228
[TBL] [Abstract][Full Text] [Related]
37. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway.
de la Iglesia N; Konopka G; Puram SV; Chan JA; Bachoo RM; You MJ; Levy DE; Depinho RA; Bonni A
Genes Dev; 2008 Feb; 22(4):449-62. PubMed ID: 18258752
[TBL] [Abstract][Full Text] [Related]
38. PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.
Benitez JA; Ma J; D'Antonio M; Boyer A; Camargo MF; Zanca C; Kelly S; Khodadadi-Jamayran A; Jameson NM; Andersen M; Miletic H; Saberi S; Frazer KA; Cavenee WK; Furnari FB
Nat Commun; 2017 May; 8():15223. PubMed ID: 28497778
[TBL] [Abstract][Full Text] [Related]
39. Genetic Ablation of
Zhang J; Xu E; Ren C; Yang HJ; Zhang Y; Sun W; Kong X; Zhang W; Chen M; Huang E; Chen X
Cancer Res; 2018 Mar; 78(6):1511-1521. PubMed ID: 29330147
[TBL] [Abstract][Full Text] [Related]
40. TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73.
Liu K; Ling S; Lin WC
Mol Cell Biol; 2011 Nov; 31(22):4464-81. PubMed ID: 21930790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]